Evolent Health (EVH) Misses Q1 EPS by 18c

Evolent Health (NYSE: EVH) reported Q1 EPS of ($0.34), $0.18 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $106.24 million versus the consensus estimate of $104.38 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• Oppenheimer Starts Amneal Pharmaceuticals (AMRX) at Outperform
• Union Pacific (UNP) Reiterated at Market Outperform by Citizens - Most Attractive in Rail Group